Pilot Growth Equity

Bizzabo Ltd. is a cloud-based event management platform that provides a comprehensive suite of tools designed to enhance the planning and execution of in-person, virtual, and hybrid events. Founded in 2011 and headquartered in Tel Aviv-Yafo, Israel, the company offers services such as registration and ticketing, event marketing, agenda management, networking applications, and data management tools. Bizzabo's platform is engineered to facilitate immersive experiences, enabling organizations to engage audiences effectively and achieve significant business outcomes while ensuring the privacy and security of attendee data. The company serves a diverse clientele, including corporations, marketing agencies, third-party planners, and associations. With a workforce of over 300 employees across offices in New York, Tel Aviv, Kyiv, London, and various remote locations, Bizzabo has established itself as a trusted partner for leading global brands in managing their events.

Tailwind is a prominent marketing platform tailored for small businesses, entrepreneurs, creators, and marketers. It provides tools that facilitate the planning, creation, execution, and optimization of marketing campaigns across various digital platforms, including email, Facebook, Instagram, and Pinterest. By integrating multiple standalone marketing tools into a unified system, Tailwind aims to empower small businesses to become effective omni-channel marketers, catering to their specific needs. Additionally, Tailwind offers a utility-first CSS framework designed to simplify content marketing, enabling users to enhance their marketing efforts and connect with a broader audience. Through its comprehensive suite of services, Tailwind is reshaping the marketing landscape for small businesses.

R4 Technologies focuses on leveraging artificial intelligence to enhance cross-enterprise management. Its innovative platform is designed to democratize data science, making it accessible to business users. By utilizing AI and machine learning, R4 Technologies processes and integrates data from various sources across companies, delivering valuable insights for yield management. This approach aims to identify and unlock growth opportunities that are often hindered by siloed systems and processes, enabling businesses to make quicker and more informed decisions.

Bizzabo Ltd. is a cloud-based event management platform that provides a comprehensive suite of tools designed to enhance the planning and execution of in-person, virtual, and hybrid events. Founded in 2011 and headquartered in Tel Aviv-Yafo, Israel, the company offers services such as registration and ticketing, event marketing, agenda management, networking applications, and data management tools. Bizzabo's platform is engineered to facilitate immersive experiences, enabling organizations to engage audiences effectively and achieve significant business outcomes while ensuring the privacy and security of attendee data. The company serves a diverse clientele, including corporations, marketing agencies, third-party planners, and associations. With a workforce of over 300 employees across offices in New York, Tel Aviv, Kyiv, London, and various remote locations, Bizzabo has established itself as a trusted partner for leading global brands in managing their events.

Counsyl is a health technology company specializing in DNA screening for individuals and families. It aims to enhance health outcomes by providing critical genetic information that can influence behaviors, preventative measures, and overall health preparedness. Operating a modern clinical laboratory, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 health professionals. The company employs advanced technology, including custom robotic automation, to efficiently process blood and saliva samples, allowing for precise analysis of DNA. Counsyl's innovative approach has garnered recognition, including the Wall Street Journal's Innovation Award for Medicine and a spot on Scientific American's list of "Top 10 World Changing Ideas." Its Family Prep Screen has enabled many to uncover vital information before starting families, while its services have expanded to include informed pregnancy and cancer screening.

Webgility, Inc., founded in 2007 and based in Scottsdale, Arizona, specializes in accounting automation software tailored for e-commerce brands, accountants, and NetSuite retailers. Its software streamlines financial processes by recording orders either individually or in summarized formats, integrating seamlessly with platforms like QuickBooks Online and NetSuite. The solution offers features such as sales forecasting, operational insights, and inventory management, allowing businesses to track metrics like average order value and growth rates. By centralizing financial data and automating workflows, Webgility enables multi-channel retail and e-commerce companies to reduce manual data entry and associated errors, thereby enhancing operational efficiency and supporting business growth.

Metabiota, Inc. focuses on assessing and investigating infectious disease threats through pathogen discovery, disease detection, and threat characterization. Founded in 2008 and headquartered in San Francisco, California, the company provides data, analytics, and training aimed at preparing for global health threats and minimizing their impacts. Metabiota's services include surveillance, recognition, and diagnosis of microbial threats, which assist in reducing and preventing outbreaks. The company employs a strategic global presence and fosters partnerships to help local authorities develop effective mitigation strategies, thereby enabling governments and organizations to better manage and respond to infectious disease risks.

Velocidi is a customer data platform based in New York, with an additional office in Porto, Portugal. The company provides a private CDP that is deployed within each client's own infrastructure, facilitating a solution that feels integrated and in-house. Velocidi's platform is designed for direct-to-consumer brands, allowing them to collect and unify first-party customer data from both online and offline sources. The platform employs machine learning to predict customer behavior and enables users to activate audience segments directly on advertising platforms. This approach ensures that clients maintain complete ownership and control of their data while measuring, reporting, and optimizing their marketing efforts in real-time, thereby supporting the creation of omnichannel and multi-device customer journeys.

Leveraging its trusted, Cloud-based, globally distributed platform, its patent-pending monitoring and mitigation technology, and its unparalleled expertise in cyberattack mitigation, Zenedge provides organizations an enterprise-class, managed white-glove cybersecurity service to help secure their web sites, web applications, and networks against vulnerabilities and Distributed Denial of Service (DDoS) attacks. Unlike other Web Application Security solutions in the market, Zenedge leverages patent-pending deep machine-learning capabilities to detect anomalies, dynamically alter security postures, and initiate auto-mitigation and automatic routing with minimal to zero human intervention. This allows the company to provide better cybersecurity and faster time to mitigation than traditional Cloud and on-premise cybersecurity vendors.

Perthera, Inc. is a biotechnology company based in McLean, Virginia, that specializes in personalized medicine and precision cancer analysis. The firm develops a therapeutic intelligence platform that provides comprehensive molecular information about cancer tumors, allowing oncologists to identify tailored treatment options for their patients. By analyzing patients' unique conditions, histories, and molecular profiles, Perthera offers actionable therapy recommendations ranked by their likelihood of success. The company's aim is to extend the lives of cancer patients by matching them with targeted medications that address specific biomarkers associated with their cancers. Perthera has established a strategic partnership with Theralink Technologies to enhance its services.

CB Insights is a market intelligence platform that specializes in predicting company health, investor performance, and technology trends. The platform analyzes millions of data points related to venture capital, startups, patents, partnerships, and market news, providing clients with comprehensive insights into privately held companies and investment opportunities. It serves a diverse clientele engaged in private equity, venture capital, corporate development, investment banking, corporate innovation, and consulting. By offering tools for deal sourcing, due diligence, and competitive intelligence, CB Insights aims to enhance the efficiency and effectiveness of its users in navigating the complex landscape of private company information.

Metabiota, Inc. focuses on assessing and investigating infectious disease threats through pathogen discovery, disease detection, and threat characterization. Founded in 2008 and headquartered in San Francisco, California, the company provides data, analytics, and training aimed at preparing for global health threats and minimizing their impacts. Metabiota's services include surveillance, recognition, and diagnosis of microbial threats, which assist in reducing and preventing outbreaks. The company employs a strategic global presence and fosters partnerships to help local authorities develop effective mitigation strategies, thereby enabling governments and organizations to better manage and respond to infectious disease risks.

Metabiota, Inc. focuses on assessing and investigating infectious disease threats through pathogen discovery, disease detection, and threat characterization. Founded in 2008 and headquartered in San Francisco, California, the company provides data, analytics, and training aimed at preparing for global health threats and minimizing their impacts. Metabiota's services include surveillance, recognition, and diagnosis of microbial threats, which assist in reducing and preventing outbreaks. The company employs a strategic global presence and fosters partnerships to help local authorities develop effective mitigation strategies, thereby enabling governments and organizations to better manage and respond to infectious disease risks.

Counsyl is a health technology company specializing in DNA screening for individuals and families. It aims to enhance health outcomes by providing critical genetic information that can influence behaviors, preventative measures, and overall health preparedness. Operating a modern clinical laboratory, Counsyl has screened over 500,000 patients and collaborated with more than 6,000 health professionals. The company employs advanced technology, including custom robotic automation, to efficiently process blood and saliva samples, allowing for precise analysis of DNA. Counsyl's innovative approach has garnered recognition, including the Wall Street Journal's Innovation Award for Medicine and a spot on Scientific American's list of "Top 10 World Changing Ideas." Its Family Prep Screen has enabled many to uncover vital information before starting families, while its services have expanded to include informed pregnancy and cancer screening.